Skip to main content

International Journal of Phytomedicine and Phytotherapy

Table 7 Changes of patient symptom status from Day 7 to Day 37 categorized by status of significant bacteriuria

From: An open label, non-controlled, multicentre, interventional trial to investigate the safety and efficacy of Canephron® N in the management of uncomplicated urinary tract infections (uUTIs)

 

Day 7

Day 37

N

%

N

%

Total (N = 125a)

Clinical cure

89

73.0

107

88.4

Improvement

24

19.7

10

8.2

Clinical failure

9

7.3

4

3.3

< 103/ml (N = 50)

Clinical cure

44

88.0b

49

98.0b

Improvement

5

10.0

1

2.0

Clinical failure

1

2.0

0

0.0

≥ 103/ml (N = 62)

Clinical cure

39

62.9b

48

77.4b

Improvement

16

25.8

9

14.5

Clinical failure

7

11.3

4

6.5

Unknown (N = 10)

Clinical cure

6

60.0

10

100.0

Improvement

3

30.0

0

0.0

Clinical failure

1

10.0

0

0.0

  1. Number (N) and percentage (%) of patients whose symptom status was assessed as “Clinical cure”, “Improvement” or “Clinical failure” on Day 7 and Day 37, for all patients and categorized into subgroups with (≥ 103 colony forming units (CFU)/ml) or without (< 103 CFU/ml) significant bacteriuria (full analysis set, N = 125)
  2. alost for follow up: 3 patients on Day 7 and 4 patients on Day 37
  3. bdifference between patients with and without significant bacteriuria is statistically significant (chi2 test; p < 0.005) on Day 7 and on Day 37